A-308 - Trial in Progress: A Phase 3 Randomised Study of Low Dose Intralesional Cemiplimab Versus Primary Surgery for Patients with Early-Stage Cutaneous Squamous Cell Carcinoma

Bibliographic Details
Title: A-308 - Trial in Progress: A Phase 3 Randomised Study of Low Dose Intralesional Cemiplimab Versus Primary Surgery for Patients with Early-Stage Cutaneous Squamous Cell Carcinoma
Authors: Migden, M. 1, Ibrahim, S. 2, Strasswimmer, J. 3, Zeitouni, N. 4, Yoo, S.-Y. 5, Seebach, F. 5, Lowy, I. 5, Cristea, M. 5, Fury, M. 5
Source: In EJC Skin Cancer 2025 3 Supplement 1
Database: ScienceDirect
More Details
ISSN:27726118
DOI:10.1016/j.ejcskn.2025.100701
Published in:EJC Skin Cancer
Language:English